Skip to content

Study · Measured the body's own peptide · 2002

1 result

Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts.

Erdag G, Morgan JR

Annals of surgery1 Jan 2002Cited by 54 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Mechanism

    In cultured keratinocytes and composite keratinocyte grafts, interleukin-1alpha increased mRNA levels of antimicrobial peptides, a group that included LL‑37.

    In plain wordsIn lab-grown skin cells, interleukin-1alpha raised the body's own antimicrobial peptide mRNA, a group that included LL‑37.

    Peptide
    LL-37
    Outcome
    IncreaseAntimicrobial peptide mRNA levels (including LL-37) after interleukin-1alpha
    Study

    n: not reported in source

    cultured composite keratinocyte grafts and keratinocytes on plastic dishes
    Outcome group
    Infection and antimicrobial activity · Skin and wound

    Source sentences

    Summary
    Treatment with interluekin-1alpha increased mRNA levels of antimicrobial peptides in keratinocytes on plastic dishes and in composite grafts.
    1 context sentence
    Summary · context
    The innate immune response of cultured composite keratinocyte grafts treated with various cytokines was assessed indirectly by measuring the levels of mRNA encoding antimicrobial peptides (human beta defensin-1 and -2, LL-37, and antileukoprotease)

    This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:00 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.